CTF Meeting 2012: Translation of the Basic Understanding of the Biology and Genetics of NF1, NF2, and Schwannomatosis Toward the Development of Effective Therapies

Brigitte C. Widemann, Maria T. Acosta, Sylvia Ammoun, Allan J. Belzberg, Andre Bernards, Jaishri Blakeley, Antony Bretscher, Karen Cichowski, D. Wade Clapp, Eva Dombi, Gareth D. Evans, Rosalie Ferner, Cristina Fernandez-Valle, Michael J. Fisher, Marco Giovannini, David H. Gutmann, C. Oliver Hanemann, Robert Hennigan, Susan Huson, David IngramJoe Kissil, Bruce R. Korf, Eric Legius, Roger J. Packer, Andrea I. Mcclatchey, Frank Mccormick, Kathryn North, Minja Pehrsson, Scott R. Plotkin, Vijaya Ramesh, Nancy Ratner, Susann Schirmer, Larry Sherman, Elizabeth Schorry, David Stevenson, Douglas R. Stewart, Nicole Ullrich, Annette C. Bakker*, Helen Morrison

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)563-578
Number of pages0
JournalAMERICAN JOURNAL OF MEDICAL GENETICS PART A
Volume164
Issue number3
DOIs
Publication statusPublished - 2014

Keywords

  • neurofibromatosis type 1
  • neurofibromatosis type 2
  • NF1
  • NF2
  • schwannomatosis
  • tumor suppressor
  • SMARCB1
  • merlin neurofibromin
  • preclinical models

Cite this